Vipul Jairath (V Jairath)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Alimentary pharmacology & therapeutics

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Sudheer Kumar Vuyyuru, Lisa M Shackelton, Jurij Hanžel, Christopher Ma, Vipul Jairath, Brian G Feagan
Targeting IL-23 for IBD: Rationale and Progress to Date. Drugs (2023)
Ahmed Almradi, Jurij Hanzel, Rocio Sedano, Claire E Parker, Brian G Feagan, Christopher Ma, Vipul Jairath
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (6) (2021)
Jurij Hanžel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G Feagan
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 81 (3) (2021)
Christopher Ma, Robert Battat, Parambir S Dulai, Claire E Parker, William J Sandborn, Brian G Feagan, Vipul Jairath
Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs 79 (12) (2019)
Christopher Ma, Leonardo Guizzetti, R Panaccione, Richard N Fedorak, Rish K Pai, C E Parker, T M Nguyen, R Khanna, Niels Vande Casteele, Geert R A M D'Haens, William J Sandborn, Brian G Feagan, Vipul Jairath
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis. Alimentary pharmacology & therapeutics 47 (12) (2018)
Christopher Ma, Vipul Jairath, Reena Khanna, Brian G Feagan
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease. Expert opinion on investigational drugs 27 (8) (2018)